David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GPOR
3126
CALL
DELISTED
Gulfport Energy Corp.
GPOR
| $351K | ﹤0.01% |
+27,500
| New | +$366K |
|
3127
Fox Factory Holding Corp
FOXF
$910M
| $349K | ﹤0.01% |
8,981
-100
| -1% | -$4.04K |
|
3128
SS&C Technologies
SSNC
$19.6B
| $348K | ﹤0.01% |
8,603
+3,326
| +63% | +$136K |
|
3129
PUT
XPO
XPO
$22.5B
| $348K | ﹤0.01% |
+10,987
| New | +$281K |
|
3130
Lexicon Pharmaceuticals
LXRX
$1.03B
| $345K | ﹤0.01% |
34,878
+3,257
| +10% | +$33.8K |
|
|
NVRO
3131
PUT
DELISTED
NEVRO CORP.
NVRO
| $345K | ﹤0.01% |
+5,000
| New | +$400K |
|
3132
Agilysys
AGYS
$3.21B
| $343K | ﹤0.01% |
27,965
+3,932
| +16% | +$48.1K |
|
3133
Illinois Tool Works
ITW
$80.9B
| $343K | ﹤0.01% |
2,055
-9,903
| -83% | -$1.58M |
|
3134
Viatris
VTRS
$19B
| $342K | ﹤0.01% |
8,094
-283,537
| -97% | -$10.8M |
|
|
DEL
3135
DELISTED
Deltic Timber
DEL
| $342K | ﹤0.01% |
+3,737
| New | +$342K |
|
|
AMRN
3136
Amarin Corp
AMRN
$292M
| $341K | ﹤0.01% |
4,253
+1,291
| +44% | +$89K |
|
3137
Atlanta Braves Holdings Series A
BATRA
$3.68B
| $341K | ﹤0.01% |
15,457
-47,850
| -76% | -$1.12M |
|
3138
New Oriental
EDU
$8.97B
| $341K | ﹤0.01% |
3,629
-1,575
| -30% | -$140K |
|
3139
First Commonwealth Financial
FCF
$2.12B
| $341K | ﹤0.01% |
23,803
+2,703
| +13% | +$39K |
|
3140
Helios Technologies
HLIO
$2.44B
| $341K | ﹤0.01% |
5,269
-12,812
| -71% | -$748K |
|
3141
Tempest Therapeutics
TPST
$18.2M
| $341K | ﹤0.01% |
83
-87
| -51% | -$365K |
|
|
CHS
3142
PUT
DELISTED
Chicos FAS, Inc.
CHS
| $341K | ﹤0.01% |
38,700
| – | – |
|
|
DO
3143
CALL
DELISTED
Diamond Offshore Drilling
DO
| $340K | ﹤0.01% |
18,300
-15,900
| -46% | -$259K |
|
3144
W.W. Grainger
GWW
$62.3B
| $339K | ﹤0.01% |
1,435
-3,339
| -70% | -$691K |
|
|
CCC
3145
DELISTED
Calgon Carbon Corp
CCC
| $338K | ﹤0.01% |
15,847
-17,153
| -52% | -$368K |
|
3146
PUT
First Majestic Silver
AG
$10.3B
| $337K | ﹤0.01% |
50,000
| – | – |
|
3147
Coherus Oncology
CHRS
$210M
| $336K | ﹤0.01% |
38,106
-68,915
| -64% | -$738K |
|
3148
CALL
Johnson Controls International
JCI
$86.6B
| $335K | ﹤0.01% |
+8,800
| New | +$344K |
|
|
RAD
3149
PUT
DELISTED
Rite Aid Corporation
RAD
| $335K | ﹤0.01% |
8,500
| – | – |
|
3150
PUT
Microchip Technology
MCHP
$40.3B
| $334K | ﹤0.01% |
7,600
| – | – |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.